155 related articles for article (PubMed ID: 37926720)
1. Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.
Vieri M; Tharmapalan V; Kalmer M; Baumeister J; Nikolić M; Schnitker M; Kirschner M; Flosdorf N; de Toledo MAS; Zenke M; Koschmieder S; Brümmendorf TH; Beier F; Wagner W
Blood Cancer J; 2023 Nov; 13(1):164. PubMed ID: 37926720
[No Abstract] [Full Text] [Related]
2. Ph-positive and -negative myeloproliferative syndromes may co-exist.
Mauro MJ; Loriaux M; Deininger MW
Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
[No Abstract] [Full Text] [Related]
3. Abnormal clones of megakaryocytes in myeloproliferative disorders.
Sato Y; Suda T
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1705-18. PubMed ID: 3471029
[No Abstract] [Full Text] [Related]
4. Myeloproliferative neoplasms: thrombophilic clonal stem cell diseases.
Tefferi A
Cancer Treat Res; 2009; 148():157-79. PubMed ID: 19377924
[No Abstract] [Full Text] [Related]
5. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Bacher U; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of clonal development in chronic myeloproliferative disorders.
Ferraris AM; Mangerini R; Racchi O; Rapezzi D; Rolfo M; Casciaro S; Gaetani GF
Am J Hematol; 1999 Feb; 60(2):158-60. PubMed ID: 9929111
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal origin of chronic myeloproliferative syndromes].
Cervantes F
Med Clin (Barc); 1983 Dec; 81(19):853-5. PubMed ID: 6656463
[No Abstract] [Full Text] [Related]
8. Analysis of myeloproliferative disorders using cell markers in culture.
Adamson JW
Haematol Blood Transfus; 1979; 23():205-10. PubMed ID: 544361
[No Abstract] [Full Text] [Related]
9. The cytogenetics of haematological malignancies.
Berger R
Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165
[No Abstract] [Full Text] [Related]
10. [Chronic granulocytic leukemia as a proliferative panmyelopathy of a clonal nature].
Sánchez Fayos J; Lasierra Cirujeda J
Sangre (Barc); 1984; 29(4-B):491-501. PubMed ID: 6393378
[No Abstract] [Full Text] [Related]
11. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.
Koschmieder S; Mughal TI; Hasselbalch HC; Barosi G; Valent P; Kiladjian JJ; Jeryczynski G; Gisslinger H; Jutzi JS; Pahl HL; Hehlmann R; Maria Vannucchi A; Cervantes F; Silver RT; Barbui T
Leukemia; 2016 May; 30(5):1018-24. PubMed ID: 26854026
[TBL] [Abstract][Full Text] [Related]
12. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2
Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L
Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666
[TBL] [Abstract][Full Text] [Related]
13. Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.
Beer PA; Jones AV; Bench AJ; Goday-Fernandez A; Boyd EM; Vaghela KJ; Erber WN; Odeh B; Wright C; McMullin MF; Cullis J; Huntly BJ; Harrison CN; Cross NC; Green AR
Br J Haematol; 2009 Mar; 144(6):904-8. PubMed ID: 19170680
[TBL] [Abstract][Full Text] [Related]
14. Neoplasms of the hematopoietic stem cell.
Adamson JW
Prog Clin Biol Res; 1985; 184():393-402. PubMed ID: 4048194
[No Abstract] [Full Text] [Related]
15. Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
Nam AS; Kim KT; Chaligne R; Izzo F; Ang C; Taylor J; Myers RM; Abu-Zeinah G; Brand R; Omans ND; Alonso A; Sheridan C; Mariani M; Dai X; Harrington E; Pastore A; Cubillos-Ruiz JR; Tam W; Hoffman R; Rabadan R; Scandura JM; Abdel-Wahab O; Smibert P; Landau DA
Nature; 2019 Jul; 571(7765):355-360. PubMed ID: 31270458
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloproliferative disorders: molecular markers and pathogenesis.
Skoda RC
Hematol J; 2004; 5 Suppl 3():S122-5. PubMed ID: 15190293
[No Abstract] [Full Text] [Related]
17. Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation.
Hussein K; Bock O; Theophile K; Schlue J; Ballmaier M; Kröger N; Göhring G; Büsche G; Kreipe H
Blood; 2009 Feb; 113(6):1391-2. PubMed ID: 19196872
[No Abstract] [Full Text] [Related]
18. [Clonal megakaryocytopathies].
Sánchez Fayos J; Pérez Sáenz M
Sangre (Barc); 1989 Aug; 34(4):259-62. PubMed ID: 2672382
[No Abstract] [Full Text] [Related]
19. Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders.
Cazzola M; Passamonti F
Haematologica; 2006 Feb; 91(2):159. PubMed ID: 16461298
[No Abstract] [Full Text] [Related]
20. Abnormal myelopoietic clones in man.
McCulloch EA
J Natl Cancer Inst; 1979 Oct; 63(4):883-92. PubMed ID: 384008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
